Patricia Mendoza-Garcia

Patricia Mendoza-Garcia

AstraZeneca, Sweden - Södertälje / Sweden
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4695680
-
person_outline Patricia Mendoza-Garcia's MOST POPULAR ARTICLES
1-) FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinaseJ Guan, G Umapathy, Y Yamazaki, G Wolfstetter, P Mendoza, K Pfeifer, ...Elife 4, e09811, 20151272015
2-) ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cellsA Fadeev, P Mendoza-Garcia, U Irion, J Guan, K Pfeifer, S Wiessner, ...Proceedings of the National Academy of Sciences, 201719137, 2018672018
3-) Targeting anaplastic lymphoma kinase in neuroblastomaG Umapathy, P Mendoza‐Garcia, B Hallberg, RH PalmerApmis 127 (5), 288-302, 2019602019
4-) ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutationM Borenäs, G Umapathy, WY Lai, DE Lind, B Witek, J Guan, ...The EMBO journal 40 (3), e105784, 2021512021
5-) Harnessing DSB repair to promote efficient homology-dependent and-independent prime editingM Peterka, N Akrap, S Li, S Wimberger, PP Hsieh, D Degtev, B Bestas, ...Nature Communications 13 (1), 1240, 2022292022